Eleonora Kay

Eleonora Kay is the commercialisation project manager for Burnext – Burnet Institute’s research translation program that fast-tracks promising health technologies into clinical and community practice. She holds a Bachelor of Biomedical Science and a Bachelor of Science (Genetics and Molecular Biology) from Monash University.

Driven by a passion to make science matter, Eleonora collaborates with clinicians, researchers, consumers and industry to tackle real patient-centred challenges. At the World Mosquito Program she worked on reducing arbovirus transmission (dengue, Zika and Chikungunya) in Aedes aegypti through the novel Wolbachia establishment model, and at Nucleus Network she coordinated first-in-human trials under ICH-GCP from start-up to close-out.

As a Project Manager with the VCCC Alliance she facilitated delivery of the Clinical Trial Innovations Program – shaping participant co-design frameworks, developing educational modules with partners (e.g. A-CTEC), and launching fit-for-purpose training programs and workshops.

She also facilitated the design and delivery of thought-leadership sessions at conferences including ARCS, ACTA and COSA to spark sector conversations and build collaborative capability.

Burnext sits within the Commercialisation and Research Translation team, which unites research streams with operational, business development, intellectual property, regulatory and commercial support, moving projects from bench to bedside and beyond.